✦ LIBER ✦

Phase II trial of fazarabine in advanced colorectal carcinoma

✍ Scribed by Kevin P. Hubbard; Karen Daugherty; Jaffer A. Ajani; Richard Pazdur; Bernard Levin; James L. Abbruzzese

Publisher: Springer US
Year: 1992
Tongue: English
Weight: 255 KB
Volume: 10
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf01275479

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of intravenous melphalan

Phase II trial of intravenous melphalan in advanced colorectal carcinoma

✍ Dennis F. Moore; Richard Pazdur; James L. Abbruzzese 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 326 KB

Phase II trial of menogaril in advanced

Phase II trial of menogaril in advanced colorectal cancer

✍ Eduard E. Holdener; Wim W. Bokkel Huinink; Genevieve Decoster; Christian Ludwig; 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 262 KB

Menogaril, a new semisynthetic anthracycline antibiotic, was administered to 35 patients with advanced colorectal cancer. The drug was infused over 2 hr at a dose of 160 mg/sqm or 200 mg/sqm repeated every 4 weeks. Twenty-seven patients were evaluable for response and no objective responses were ach

Phase II trial of fazarabine (arabinofur

Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma

✍ Ephraim S. Casper; Gary K. Schwartz; David P. Kelsen 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 365 KB

Treatment of advanced colorectal carcino

Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine : A Phase II trial

✍ Anthony F. Shields; Mark M. Zalupski; John L. Marshall; Neal J. Meropol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## Abstract ## BACKGROUND The current study was designed to evaluate the antitumor activity and toxicity of capecitabine and oxaliplatin in previously untreated patients with advanced colorectal carcinoma. The primary endpoint of the study was to determine the objective response rate, and a second

Phase II trial of irinotecan in combinat

Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma

✍ Maria L. Delioukina; Diane Prager; Mandy Parson; J. Randolph Hecht; Peter Rosen; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Phase II trial of vinblastine in advance

Phase II trial of vinblastine in advanced ovarian carcinoma

✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro